“A Review of the Genetic Variants Affecting Efficacy and Adverse Effects of Standard of Care Treatment in Patients with Chronic Myelogenous Leukemia”, Precis. Med. Com., vol. 2, no. 1, pp. 43–58, Jun. 2022, doi: 10.55627/pmc.002.01.0045.